101 results on '"Hoag, Stephen W."'
Search Results
2. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media
3. Development of Protein–Polymer Conjugate Nanoparticles for Modulation of Dendritic Cell Phenotype and Antigen-Specific CD4 T Cell Responses
4. Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder
5. Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of Clostridium difficile infection (CDI)
6. Quality-by-Design (QbD) for Capsule Formulation and Process Development
7. Advances in Capsule Formulation Development and Technology
8. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets
9. Formulation of smokeless tobacco products with a wide range of pH to study nicotine pharmacokinetics and pharmacodynamics
10. Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans
11. A method for the tribological assessment of oral pharmaceutical liquids
12. Impact assessment of the variables affecting the drug release and extraction of polyethylene oxide based tablets
13. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation
14. Impact Assessment of the Variables Affecting the Drug Release and Extraction of Polyethylene Oxide Based Abuse Deterrent Tablets
15. Spray layering of human immunoglobulin G: Optimization of formulation and process parameters
16. Application of near-infrared spectroscopy in detecting residual crystallinity in carbamazepine – Soluplus® solid dispersions prepared with solvent casting and hot-melt extrusion
17. Effects of compaction and storage conditions on stability of intravenous immunoglobulin – Implication on developing oral tablets of biologics
18. Pediatric formulation development – Challenges of today and strategies for tomorrow: Summary report from M−CERSI workshop 2019
19. Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies
20. Hedgehog pathway inhibitors significantly reduce the formation of heterotopic ossification in a direct trauma/burn mouse model
21. The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions
22. 3D Nanoprinted Liquid-Core-Shell Microparticles
23. In Vitro Gastrointestinal Digestion of Palm Olein and Palm Stearin-in-Water Emulsions with Different Physical States and Fat Contents
24. Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets
25. L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia
26. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions
27. Understanding the impact of magnesium stearate variability on tableting performance using a multivariate modeling approach
28. Probing Thermal Stability of Proteins with Temperature Scanning Viscometer
29. Standardization of In Vitro Testing During Development of Abuse‐Deterrent Opioids: Highlights From the Second and Third Category 1 Focus Group Meetings
30. Prediction of Dissolution of Sustained Release Coated Ciprofloxacin Beads Using Near-infrared Spectroscopy and Process Parameters: a Data Fusion Approach
31. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing
32. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
33. Elucidating the Variability of Magnesium Stearate and the Correlations With Its Spectroscopic Features
34. Early detection of capping risk in pharmaceutical compacts
35. Comparing a Statistical Model and Bayesian Approach to Establish the Design Space for the Coating of Ciprofloxacin HCl Beads at Different Scales of Production
36. Physical barrier type abuse-deterrent formulations: monitoring sintering-induced microstructural changes in polyethylene oxide placebo tablets by near infrared spectroscopy (NIRS)
37. Development and validation of a HPLC with fluorescence detection method to quantify the peanut allergen Ara h 2 in peanut extract and sublingual films
38. Developing a stable aqueous enteric coating formulation with hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) and colloidal silicon dioxide as anti-tacking agent
39. Impact of formulation excipients on the thermal, mechanical, and electrokinetic properties of hydroxypropyl methylcellulose acetate succinate (HPMCAS)
40. In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell
41. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions
42. A Multiparticulate Delivery System for Potential Colonic Targeting Using Bovine Serum Albumin as a Model Protein
43. Lubricant-Sensitivity Assessment of SPRESS® B820 by Near-Infrared Spectroscopy: A Comparison of Multivariate Methods
44. A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed Process
45. Erratum to: Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin
46. Reply to “On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs”
47. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference
48. Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir
49. Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis
50. Application of Multivariate Strategies to the Classification of Pharmaceutical Excipient Manufacturers Based on Near-Infrared (NIR) Spectra
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.